Results 111 to 120 of about 1,700 (160)
Nivolumab-Induced Fasciitis Mimicking Scleroderma: A Diagnostic Challenge. [PDF]
CureusJannat R, Kshatri M, Thapa R.
europepmc +1 more source
Nodular (keloidal) scleroderma: A case series of 5 patients. [PDF]
JAAD Case RepNtiri M, Nazarian A, Magro C, Alexis AF.
europepmc +1 more source
A Review on Cutaneous Manifestations of Cerebrovascular Accident. [PDF]
Indian Dermatol Online JGowda SK, Gupta S, Verma P.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2023
Soumya Chatterjee, Anthony P. Fernandez
openaire +3 more sources
Soumya Chatterjee, Anthony P. Fernandez
openaire +3 more sources
Clinics in Dermatology, 2006
Scleromyxedema is a rare cutaneous mucinous disease characterized by a generalized papular sclerodermoid eruption and systemic manifestations that can lead to significant morbidity and mortality. Although its etiology remains unknown, most theories focus on a pathogenic role by paraproteins; it must be noted, however, that nonparaprotein factors have ...
Clara-Dina, Cokonis Georgakis +3 more
+6 more sources
Scleromyxedema is a rare cutaneous mucinous disease characterized by a generalized papular sclerodermoid eruption and systemic manifestations that can lead to significant morbidity and mortality. Although its etiology remains unknown, most theories focus on a pathogenic role by paraproteins; it must be noted, however, that nonparaprotein factors have ...
Clara-Dina, Cokonis Georgakis +3 more
+6 more sources
Journal of the American Academy of Dermatology, 1999
Scleromyxedema is a sclerotic variant of papular mucinosis, in which lichenoid papules and scleroderma-like features are present. We describe a patient with scleromyxedema with IgG type lambda chain paraprotein, a systemic sclerosis-like illness, and myositis.
Z, Bata-Csorgo +6 more
openaire +2 more sources
Scleromyxedema is a sclerotic variant of papular mucinosis, in which lichenoid papules and scleroderma-like features are present. We describe a patient with scleromyxedema with IgG type lambda chain paraprotein, a systemic sclerosis-like illness, and myositis.
Z, Bata-Csorgo +6 more
openaire +2 more sources
Journal of the American Academy of Dermatology, 1995
Scleromyxedema is a rare fibromucinous disorder that is often difficult to treat and that is associated with significant morbidity and mortality.Our purpose was to study the natural history of the disease and its response to therapy with alkylating agents.A clinicopathologic review of 26 patients with scleromyxedema was performed, and the ...
A M, Dinneen, C H, Dicken
openaire +2 more sources
Scleromyxedema is a rare fibromucinous disorder that is often difficult to treat and that is associated with significant morbidity and mortality.Our purpose was to study the natural history of the disease and its response to therapy with alkylating agents.A clinicopathologic review of 26 patients with scleromyxedema was performed, and the ...
A M, Dinneen, C H, Dicken
openaire +2 more sources
Archives of Dermatology, 1969
A 65-year-old woman developed typical scleromyxedema, with the associated M-type abnormal serum protein and marrow plasmacytosis. Treatment with systemic melphalan resulted in a dramatic response. The dermatosis improved noticeably after one month and a biopsy taken after five months of therapy showed almost total restitution to normal. The response of
T, Horio, I, Yonezawa
+7 more sources
A 65-year-old woman developed typical scleromyxedema, with the associated M-type abnormal serum protein and marrow plasmacytosis. Treatment with systemic melphalan resulted in a dramatic response. The dermatosis improved noticeably after one month and a biopsy taken after five months of therapy showed almost total restitution to normal. The response of
T, Horio, I, Yonezawa
+7 more sources